Shinhan Slips After Earnings, But the Street Sees 52% Upside
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Shinhan Financial Group posted a solid quarterly result last week, gained 2.7% on the day of the print, and has since given most of that back, leaving the stock down 18% over the past month at KRW 85,600 and sitting at a material discount to where analysts think it belongs.
The valuation gap is the central tension here. The analyst consensus price target stands at KRW 130,123, implying roughly 52% upside from current levels. The stock trades at just 6.5 times earnings and 0.64 times book. Both multiples have compressed further over the past 30 days: the P/E has fallen by about 1.2 turns and the price-to-book by 0.14 points as the share price dropped. That compression has pushed the earnings yield to the 81st percentile of the ORTEX universe, and the dividend score ranks in the 93rd percentile, making the valuation case about as plain as it gets for a large Korean financial. What it does not explain is why the stock keeps falling.
The lending market offers no structural short story to point at. Short interest is negligible at around 0.1% of the free float. Borrow availability, while tighter than it was at the start of the week, is still extremely loose: availability has eased from the capped reading of 9,999% that persisted through most of October to 7,652% now, meaning shares available to borrow remain vastly in excess of shares already borrowed. Borrowing costs have risen 72% over the past week to 0.46%, which sounds dramatic but reflects a move from an already very low base. This is not a market being organised against the stock.
The buyback announced on 27 October for up to 5.26 million shares adds a layer of corporate support. At the current price, that authorization covers meaningful capital return, though as noted in prior coverage it remains an authorization rather than a confirmed purchase programme. What has changed since that announcement is the price: shares have slipped further, making the buyback, if executed, incrementally more accretive than when it was filed. BlackRock lifted its stake to 10.7% of shares as of end-September, adding more than 17 million shares in the period reported. Capital Research and Management holds just above 5%. The institutional register is long-biased and weighted toward value-oriented global managers, which fits the cheap-on-every-metric profile but also means the stock lacks the catalyst-chasing growth holders who might react quickly to positive news flow.
One contextual data point from ORTEX Alt Data: the FDIC call report series, which covers Shinhan's US-chartered banking subsidiaries, shows net loans and leases rising for eight consecutive quarters as of Q2 2026, with net income at those subsidiaries up 73% year-on-year in the same period. This dataset has not yet been tested against Shinhan's consolidated reported figures, so no lead relationship can be claimed, but it adds texture to the picture of a financial group that is growing its US lending book while the Korean-listed shares trade at a steep discount to book.
The post-earnings reaction last week (up 2.7% on the day, essentially flat over five days) is now the recent anchor: the next scheduled print is February 2027, leaving the stock to trade on macro and sentiment for the next three months. The most consequential variable to track is whether the KRW 130,000 analyst target starts to move lower as the gap to the current price widens, or whether the buyback creates a visible floor in the order book that changes the near-term tape.
Stocks in this article
See the live data behind this article on ORTEX.
Open A055550 on ORTEX →How this article was generated
- Generated
- 4 Nov 2026, 19:21
- Data as of
- 4 Nov 2026, 19:20
- Prompt version
- v1.0
- Data sources
- Cost to borrowUtilizationEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt DataPrevious Mi Articles
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.